0000899243-18-013418.txt : 20180518 0000899243-18-013418.hdr.sgml : 20180518 20180518161627 ACCESSION NUMBER: 0000899243-18-013418 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180516 FILED AS OF DATE: 20180518 DATE AS OF CHANGE: 20180518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ekman Lars CENTRAL INDEX KEY: 0001376117 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35676 FILM NUMBER: 18846835 MAIL ADDRESS: STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC. STREET 2: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prothena Corp plc CENTRAL INDEX KEY: 0001559053 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ADELPHI PLAZA STREET 2: UPPER GEORGE'S STREET CITY: DUN LAOGHAIRE, CO. DUBLIN STATE: L2 ZIP: A96 T927 BUSINESS PHONE: 011-353-1-236-2500 MAIL ADDRESS: STREET 1: ADELPHI PLAZA STREET 2: UPPER GEORGE'S STREET CITY: DUN LAOGHAIRE, CO. DUBLIN STATE: L2 ZIP: A96 T927 FORMER COMPANY: FORMER CONFORMED NAME: Neotope Corp Ltd DATE OF NAME CHANGE: 20120926 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-16 0 0001559053 Prothena Corp plc PRTA 0001376117 Ekman Lars C/O PROTHENA BIOSCIENCES INC 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 0 0 1 Chairman of the Board Ordinary Shares, par value $0.01 per share 243 D Stock Option (right to buy) 16.43 2018-05-16 4 A 0 12000 0.00 A 2028-05-16 Ordinary Shares 12000 12000 D The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2019 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. /s/ A.W. Homan, as Attorney-in-Fact for Lars G. Ekman 2018-05-18